Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors

Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors

ObjectiveThis article aims to analyze the safety and efficacy of Erdafitinib in the treatment of patients with advanced solid tumors harboring FGFR1–4 mutations.MethodsSearch for relevant articles in databases such as PubMed, Embase, The Cochrane Library, Web of Science, and CNKI, covering the perio...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyu Huang, Zihan Wang, Fei Zhao, Adilai Aisa, Shengkai Tian, Siyuan Chen, Lianyi Peng, Xiaolu Yang, Jianxin He, Yue Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
erdafitinib
urothelial carcinoma
FGFR1-4
tumors
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1571434/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1571434/full

Similar Items